Nazara Technologies Limited informs the Exchange regarding grant of 5,66,463 employees stock options to the eligible employee of the Company under the Nazara Technologies Employee Stock Option Scheme 2025. ("Nazara ESOP 2025")
NAZARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nazara Technologies has granted 5,66,463 employee stock options to an eligible employee under its Nazara ESOP 2025 scheme. The exercise price has been set at Rs. 264.80 per option, which is the closing price of the company's shares on NSE on February 27, 2026 (the exchange with the highest trading volume). Each option converts into one equity share of face value Rs. 2. There is a minimum 1-year gap between grant and vesting, and the options must be exercised within 5 years of vesting. No lock-in applies on shares arising from exercise of these options. The grant was approved by the Nomination, Remuneration and Compensation Committee on March 2, 2026.
This is a routine ESOP grant at market price with no preferential pricing benefit, so it should be largely neutral for existing shareholders. The potential dilution of around 5.66 lakh shares is small relative to Nazara's total share base, and tying a key employee to the company through stock options is generally a mildly positive signal for long-term alignment.